An analysis of patient-reported outcomes among epidural steroid injection clinical trials
Authors:
Open Access
- 13 July 2025
- journal article
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 51 (11) , 1351-1353
Abstract
Robust reporting of randomized controlled trials (RCTs) lets clinicians judge the credibility of new pain interventions. The CONSORT (Consolidated Standards of Reporting Trials) 2010 statement and its patient-reported outcome (PRO) extension list the details readers need to interpret PRO data.1 2 Epidural steroid injections (ESIs) remain one of the most common spine procedures, yet the adequacy of PRO reporting in ESI RCTs is unknown.3 We evaluated adherence to CONSORT-PRO in these trials.Keywords
This publication has 6 references indexed in Scilit:
- CONSORT 2025 statement: updated guideline for reporting randomized trialsNature Medicine, 2025
- Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviewsQuality of Life Research, 2022
- Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extensionQuality of Life Research, 2017
- Growth of Spinal Interventional Pain Management TechniquesSpine, 2013
- Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journalsCochrane Database of Systematic Reviews, 2012
- Efficacy of Lumbosacral Transforaminal Epidural Steroid Injections: A Systematic ReviewPM&R, 2009